logo-loader
NASDAQ:NBRV

Nabriva Therapeutics Plc

Receive alerts
Market:
NASDAQ
Market Cap:
$119.13 m
Price
1.26 USD
Change
-2.71%
52 weeks high
3.27
52 weeks low
1.17

In brief

Nabriva is a clinical-stage biopharmaceutical company engaged in the research and development of novel antibiotics to treat serious infections, with a focus on the pleuromutilin class of antibiotics.